Loading...
•
Mar 31, 2025
Medpace Q1 2025 Earnings Report
Medpace reported solid revenue and earnings growth in Q1 2025, though new business awards declined year-over-year.
Key Takeaways
Medpace delivered strong financial results in Q1 2025 with revenue reaching $558.6 million and net income at $114.6 million. However, the company experienced a decline in net new business awards, reflecting a softer demand environment compared to the prior year.
Forward Guidance
Medpace anticipates modest revenue and earnings growth for the full year 2025 with EBITDA expected to reach up to $492 million.
Positive Outlook
- Revenue guidance for FY25 set between $2.14B and $2.24B
- Expected GAAP net income of $378M to $402M
- Forecasted EPS range of $12.26 to $13.04
- EBITDA guidance between $462M and $492M
- Effective tax rate projected between 15.5% and 16.5%
Challenges Ahead
- Revenue growth range implies limited upside vs. FY24
- Guidance excludes impact of future share repurchases
- Book-to-bill ratio dropped to 0.90x
- Net new business awards down 18.8% YoY
- Cash position decreased significantly from previous quarter
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...